EVALUATION OF THE USE OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW. REMUNOM [Internet]. 2024 Nov. 30 [cited 2025 Aug. 26];12(3):1-13. Available from: https://remunom.ojsbr.com/multidisciplinar/article/view/3138